Vantage Consulting Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Vantage Consulting Group's MRK Position: Q3 2024 in Review
Vantage Consulting Group sold out of Merck (MRK) in Q3 2024, closing a stake of 1,798 shares — an estimated $223K sold.
Vantage Consulting Group first reported a position in MRK in Q4 2020 and held it in 14 quarters. The position peaked at $274K in Q4 2021. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.
- Vantage Consulting Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
- Vantage Consulting Group sold 1,798 Merck shares in Q3 2024, an estimated $223K.
- Vantage Consulting Group first reported a position in Merck in Q4 2020 and held it in 14 quarters.
- Vantage Consulting Group's Merck position peaked at $274K in Q4 2021.
- 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.
Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.